<DOC>
	<DOCNO>NCT01932515</DOCNO>
	<brief_summary>The trial three stage translate validate screening assessment instrument use deaf child . The first stage modify screen assessment instrument ( ADI-R ADOS-2 ) use deaf child . This involve choose promise screen instrument ( SRS-2 ) base systematic review expertise review panel , contain expert public patient involvement ( PPI ) . This phase study seek wide range user ( parents/ carers young people ) view experience symptomatology presentation deaf child autism , compare hear child autism , deaf child without autism . The second stage ensure newly modify instrument accessible deaf child deaf parent make necessary translation English British Sign Language . This involve strict translation back translation methodology reiteration successful translation achieve . For stage three order ensure new questionnaire successfully identify child young people Autism Spectrum Disorder , modify instrument validate use 'gold standard ' . The current 'gold standard ' mental health screen Deaf child clinical interview administer experienced senior multidisciplinary deaf child mental health clinician .</brief_summary>
	<brief_title>Diagnostic Instruments Autism Deaf Children Study</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<criteria>For purpose study , child young people recruit chronological age â‰¥18 month old , 18 year . Deaf child hear loss least 40dB This pragmatic trial recognises frequency complexity comorbidities child Autistic Spectrum Disorders ( ASD ) deafness . We therefore exclude basis comorbidity group diagnosis ASD already exist , since tool would use population adopt widely NHS . We exclude child young people language delay child ASD may severe language delay . Families parent either signed language study , language ADIR available , include .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>